Back to Journals » OncoTargets and Therapy » Volume 8

p27Kip1 and Ser10-phosphorylated p27Kip1 in breast cancer: clinical significance and expression

Authors Song W, Xie RL, Zhu AY, Xu YM, Shi YQ, Shen Y, Zhang WW, Yang F, Guan XX

Received 1 April 2015

Accepted for publication 20 May 2015

Published 24 July 2015 Volume 2015:8 Pages 1863—1869

DOI https://doi.org/10.2147/OTT.S85866

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Professor Daniele Santini

Wei Song,1* Ruilian Xie,2* Aiyu Zhu,1 Yumei Xu,1 Yaqin Shi,3 Yan Shen,3 Wenwen Zhang,3 Fang Yang,3 Xiaoxiang Guan1,3

1Department of Medical Oncology, Jinling Hospital, Southern Medical University, Guangzhou, 2Department of Medical Oncology, The First Affiliated Hospital of Gannan Medical College, Ganzhou, 3Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, People’s Republic of China

*These authors contributed equally to this work

Background: The protein p27 (p27Kip1) is a member of the cyclin-dependent kinase inhibitor family, which negatively regulates cell cycle progression, and the phosphorylation of p27 has been proven to affect its stability and nuclear export. Clinical studies on the relation between p27 and phosphorylated p27 (p-p27Ser10) in breast invasive ductal carcinomas are still scarce.
Methods: We examined the expression of p27 and p-p27Ser10 using immunohistochemistry in 107 breast invasive ductal carcinomas and analyzed the relationship of these biomarkers and tumor characteristics.
Results: Of the 107 tumor samples, 38.3% (41 of 107) overexpressed p27 and 64.5% (69 of 107) overexpressed p-p27Ser10. Analysis of correlation with clinical characteristics showed that high expression level of p-p27Ser10 was linked to poor differentiation, advanced disease stage, and lymph node metastasis, whereas a contrary trend was observed for p27 (all P<0.05). In addition, the expression of p-p27Ser10 was significantly higher in malignant tumors than in adjacent tissues, while p27 showed the opposite trend. Also, there were different levels of p27 and p-p27Ser10 in different types of breast cancer.
Conclusion: p27 and p-p27Ser10 are involved in the development of invasive ductal carcinoma and are potential indicators to judge the degree of malignancy as well as recurrence and metastasis.

Keywords: breast cancer, p27, p-p27Ser10, Ki67, ERα, PR, Her2

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other article by this author:

3´ untranslated region 1630 C>T polymorphism of prohibitin increases risk of breast cancer

Tang L, Zhao Y, Nie W, Wang Z, Guan X

OncoTargets and Therapy 2013, 6:177-182

Published Date: 9 March 2013

Readers of this article also read:

miR-20b overexpression is predictive of poor prognosis in gastric cancer

Xue TM, Tao LD, Zhang M, Xu GC, Zhang J, Zhang PJ

OncoTargets and Therapy 2015, 8:1871-1876

Published Date: 24 July 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010